Glanbia shares plunge 7% as it reiterates commitment to SlimFast despite 'drag'

The pharma industry has gobbled up the weight-loss market, especially in the last year, with blockbuster drugs including Ozempic

the SlimFast brand is 'certainly dragging us a little bit more than we’d like this year,' said chief financial officer Mark Garvey.

Irish nutrition giant Glanbia shares plunged 7% after its interim statement gave a mixed financial performance for the company so far this year. 

Chief financial officer Mark Garvey suggested company is committed to its SlimFast products under the new leadership of Hugh McGuire following the retirement of Siobhán Talbot last year despite it becoming a dead weight on its Glanbia Nutritional Performance (GPN) division.